Add BrightSurf on Google Email

UT Southwestern Medical Center


Studies reveal methods viruses use to sidestep immune system

Researchers discover how hepatitis C virus (HCV) replicates unchecked despite the presence of immune defenses triggered by the RIG-I protein. HCV produces a viral protease that disrupts the signaling pathway, allowing it to continue replication. Protease inhibitors show promise in treating HCV and possibly other viral infections

SourceUT Southwestern Medical Center·JournalProceedings of the National Academy of Sciences·DateFeb 14, 2005

Auditory screening for newborns can be successful, UT Southwestern researchers report

Researchers at UT Southwestern Medical Center successfully implemented Universal Newborn Hearing Screening, reducing the number of false positives and increasing follow-up rates. Rescreening infants four hours after birth improved outcomes, while providing outpatient retesting encouraged parents to return for further evaluation.

SourceUT Southwestern Medical Center·JournalThe Journal of Pediatrics·DateJan 27, 2005

Exercise helps reduce symptoms of depression, UT Southwestern researchers find

A study published in the American Journal of Preventive Medicine found that exercising moderately intense aerobics for 30-35 minutes per day reduced depressive symptoms by an average of 47% after 12 weeks. The study included 80 adults with mild to moderate depression and showed similar results to antidepressant medications.

SourceUT Southwestern Medical Center·JournalAmerican Journal of Preventive Medicine·DateJan 25, 2005

UT Southwestern researchers find calcium intake contributing factor in formation of kidney stones

Researchers found that urinary calcium levels play a significant role in the formation of both calcium oxalate and calcium phosphate stones. The studies suggest that patients with elevated intestinal calcium absorption and urinary calcium levels may need to limit their calcium intake to prevent kidney stone formation.

SourceUT Southwestern Medical Center·JournalThe Journal of Urology·DateDec 28, 2004

Researchers find circulating tumor cells in long-term cancer survivors

A recent study by UT Southwestern Medical Center found that one-third of long-term disease-free breast cancer patients have circulating tumor cells (CTCs), which are often associated with a higher risk of recurrence. However, the presence of CTCs in these patients after 20 years post-mastectomy is notable due to their low risk of recur...

SourceUT Southwestern Medical Center·JournalClinical Cancer Research·DateDec 15, 2004

UT Southwestern researchers locate gene family involved in determining potential for acquiring lupus

Researchers at UT Southwestern Medical Center have identified a gene family involved in determining the potential for acquiring lupus, a debilitating autoimmune disease that affects more than one million Americans. The study found that genetic susceptibility to lupus results from an imbalance between genes that increase and suppress th...

SourceUT Southwestern Medical Center·JournalImmunity·DateDec 14, 2004

Research points to new theory driving evolutionary changes

Researchers at UT Southwestern Medical Center propose a new theory explaining the rapid evolution of species and their physical variations. They found that tandem repeat sequences in genetic code can lead to significant morphological changes, driving evolutionary changes and variability in appearance among individual members of a species.

SourceUT Southwestern Medical Center·JournalProceedings of the National Academy of Sciences·DateDec 13, 2004

Generic anti-inflammatory causes significantly fewer GI complications than branded medications

A new study published in Gastroenterology found that generic anti-inflammatory drug etodolac reduces rates of gastrointestinal complication by more than 60% compared to naproxen, resulting in fewer hospitalizations and cost savings. This significant finding has led the Pharmacy Benefits Management Strategic Healthcare Group for the Vet...

SourceUT Southwestern Medical Center·JournalGASTROENTEROLOGY·DateNov 11, 2004

New medication dramatically decreases congestive heart failure in African-American patients

African-American Heart Failure Trial (A-HeFT) reveals a 43% decrease in one-year mortality rates among patients taking the combined treatment, and significant improvements in overall survival and quality of life. The study suggests that BiDil can slow heart failure progression and reduce death rates in this population.

SourceUT Southwestern Medical Center·JournalNew England Journal of Medicine·DateNov 8, 2004